Takeda Pharmaceutical Company Limited. has launched an early retirement scheme as part of what the Japanese firm says is an ongoing effort to hone its strategic focus on five core therapeutic areas, and as it continues to rationalize its operations and practices globally following the January 2019 acquisition of Shire Pharmaceuticals Group PLC.
The “Future Career Program” will be open to sales, administrative and other staff in Japan (but excluding R&D and manufacturing)...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?